-- Sanj K Patel, Director, Chairman and Chief Executive Officer,, on April 28, 2026, sold 508,339 shares in Kiniksa Pharmaceuticals International (KNSA) for $26,415,228. Following the Form 4 filing with the SEC, Patel has control over a total of 237,763 Class A ordinary shares of the company, with 237,763 controlled indirectly.
SEC Filing:
Coherent (COHR) has an average rating of overweight and mean price target of $320.02, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Lumentum Holdings (LITE) has an average rating of overweight and mean price target of $861.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Ciena (CIEN) has an average rating of overweight and mean price target of $409.76, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)